Search for: "Anda Pharmaceuticals, Inc"
Results 381 - 400
of 607
Sorted by Relevance
|
Sort by Date
24 Feb 2009, 2:22 pm
USA, Inc., No. 2009–1071 (Fed. [read post]
14 May 2010, 4:00 am
’s (“Sandoz’s”) ANDA No. 40-445 for a generic version of King Pharmaceuticals, Inc. [read post]
1 Apr 2014, 7:17 pm
Procedural HistoryPlaintiffs- Appellants Senju Pharmaceutical Co., Ltd., Kyorin Phar- maceutical Co., Ltd., and Allergan, Inc. [read post]
3 Feb 2012, 7:12 am
Mylan, Inc. [read post]
30 Dec 2010, 5:48 am
Karst – Amphastar Pharmaceuticals Inc. [read post]
15 Aug 2019, 11:16 am
by Dennis Crouch Nalpropion Pharmaceuticals, Inc. v. [read post]
26 Mar 2013, 5:17 pm
Actavis, Inc: A Quick Look into Reverse Paymentsby George YuThe name of the game in the pharmaceutical industry is exclusivity. [read post]
27 Aug 2019, 2:03 am
In contrast to its decision in Nuvo Pharmaceuticals, Inc. v. [read post]
18 Jul 2018, 11:23 am
Teva Pharmaceuticals USA, Inc., a case with broad implications for the pharmaceutical industry. [read post]
27 Sep 2013, 5:47 am
Reddy'sThe CAFC reversed:Sunovion Pharmaceuticals, Inc. [read post]
11 Jan 2022, 6:04 am
Mylan Pharmaceuticals Inc. [read post]
20 Apr 2012, 10:36 am
Plaintiffs/Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca AB, IPR Pharmaceuticals, Inc., and The Brigham and Women’s Hospital, Inc. [read post]
15 Jun 2007, 8:11 am
Align Technology, Inc. etc). [read post]
25 Jul 2008, 2:11 am
In Ortho-McNeil Pharmaceutical, Inc. v. [read post]
28 Jul 2011, 8:09 pm
., Inc. v. [read post]
4 Aug 2008, 4:39 am
KV's motion relied on Q-Pharma, Inc. [read post]
24 Jan 2012, 6:34 pm
Akorn’s ANDA, which FDA has not yet tentatively approved, contains a Paragraph IV certification to the ‘269 patent; however, according to the court, non-party Teva Pharmaceuticals USA, Inc. [read post]
7 May 2012, 10:51 am
Sandoz, Inc. [read post]
1 Jun 2012, 1:58 pm
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®ShareTweetTeva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
4 Aug 2010, 12:21 am
Mylan Pharmaceuticals Inc. [read post]
